(Q46731748)

English

A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumonia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumonia (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

0 references

1 reference

based on heuristic

inferred from title

author name string

Andrew F Shorr

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

Neringa Zadeikis

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

Jim X Xiang

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

Alan M Tennenberg

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

E Wes Ely

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

27

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

1251-1259

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

Pneumonia in Older Persons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumonia in the very old

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement, correlates, and health outcomes of medication adherence among seniors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for o

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ertapenem therapy for community-acquired pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoroquinolones in the elderly: safety considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Seizures associated with fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of three fluoroquinolones on QT interval in healthy adults after single doses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe hyperglycemia during gatifloxacin therapy in patients without diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980214-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(05)80214-0

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16199249

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46731748&oldid=2128971774"